Skip to content

Development and External Validation of a Diagnostic Model for Intraoperative Hypotension During Primary Percutaneous Coronary Intervention

Development and External Validation of a Diagnostic Model for Intraoperative Hypotension During Primary Percutaneous Coronary Intervention

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025706
Enrollment
Unknown
Registered
2019-09-06
Start date
2019-09-10
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-segment elevation myocardial infarction

Interventions

Gold Standard:Invasive blood pressure
Index test:a&#32
diagnostic&#32
model&#32
for&#32
hypotension&#32
(PPCI).

Sponsors

Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute STEMI presenting within 12 hours from the symptom onset who were treated with PPCI; 2. Aged more than 18 years and less than 80 years, male and non pregnant women. 3. The term acute myocardial infarction (AMI) should be used when there is acute myocardial injury with clinical evidence of acute myocardial ischaemia and with detection of a rise and/or fall of cTnI values with at least one value above the 99th percentile upper reference limit and at least one of the following: (1) Symptoms of myocardial ischaemia; (2) New ischaemic ECG changes. The diagnosis of STEMI was established in the presence of chest pain lasting for > 20 minutes associated with electrocardiographic changes (ST-segment elevation of > 1 mm in at least 2 extremity electrocardiographic leads or > 2 mm in at least 2 contiguous precordial leads). 4. The diagnosis was confirmed by coronary angiography in all patients.

Exclusion criteria

Exclusion criteria: 1. Patients undergoing thrombolysis; 2. Patients received bivalirudin; 3. cardiac rupture, ventricular septal perforation and other mechanical complications; 4. pulmonary embolism, aortic dissection, disseminated intravascular coagulation, and acute cerebrovascular disease.

Design outcomes

Primary

MeasureTime frame
blood pressure;

Countries

China

Contacts

Public ContactLi Yong

Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University

liyongdoctor@sina.com+86 13910227262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026